Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acerus Pharmaceuticals Corporation
Acerus Pharmaceuticals Corporation
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Natesto
Testosterone
2014-05-28
2024-2039
Breast neoplasms
,
Hypogonadism
,
Delayed puberty
,
Psychological sexual dysfunctions
Noctiva
Desmopressin
2017-03-03
2024-2030
Hemorrhage
,
Thrombocytopenia
,
Von willebrand diseases
,
Neurogenic diabetes insipidus
,
Enuresis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Testosterone
psychological sexual dysfunctions
,
hypogonadism
,
eunuchism
,
erectile dysfunction
,
physiological sexual dysfunction
,
cardiovascular diseases
Testosterone undecanoate
psychological sexual dysfunctions
,
hypogonadism
,
eunuchism
,
erectile dysfunction
,
physiological sexual dysfunction
,
cardiovascular diseases
Testosterone enanthate
psychological sexual dysfunctions
,
hypogonadism
,
eunuchism
,
erectile dysfunction
,
physiological sexual dysfunction
,
cardiovascular diseases
Ademetionine
hypogonadism
Doconexent
hypogonadism
Follitropin
eunuchism
,
hypogonadism
Levosalbutamol
asthma
Endocrine
hypogonadism
Sustanon
hypogonadism
,
eunuchism
,
erectile dysfunction
,
physiological sexual dysfunction
,
cardiovascular diseases
Arm1
hypogonadism
Arm2
hypogonadism
Demand
erectile dysfunction
,
physiological sexual dysfunction
Dpi
asthma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use